Francois Delhommeau

Head

Assistance Publique - Hôpitaux de Paris

France

Research Interests

Explore related searches

Professors in France Professors in Immunology Immunology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Francois Delhommeau is the Head at Assistance Publique - Hôpitaux de Paris, France. His research primarily focuses on acute myeloid leukemia, exploring topics such as ATP-binding cassette transporter activity, germline mutations, and the impact of DNA methylation on gene expression. He has contributed to numerous studies addressing the prognostic factors in leukemia, including the assessment of minimal residual disease and the role of cytokines in hematological disorders.

Articles (10)

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (3)

Thierry Roger

Associate Professor

Université de Lausanne Faculté de biologie et de médecine

SWITZERLAND

View details

Françoise PORTEU

INSERM

FRANCE

View details

Shengjiang Tan

University of Cambridge

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Francois Delhommeau

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Macrophage migration inhibitory factor is overproduced through EGR1 in TET2low resting monocytes

Publisher Correction: Somatic genetic rescue of a germline ribosome assembly defect.

Clinical and biological impact of ATP-binding cassette transporter activity in adult acute myeloid leukemia

Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study.

Aberrant DNA methylation impacts HOX genes expression in bone marrow mesenchymal stromal cells of myelodysplastic syndromes and de novo acute myeloid leukemia

Isocitrate dehydrogenase inhibitors as a bridge to allogeneic stem cell transplant in relapsed or refractory acute myeloid leukaemia.

Gaucher's Disease.

Prognostic impact of early minimal residual disease combined with complete molecular evaluation in acute myeloid leukemia with mutated <i>NPM1</i>: a single center study.

Dominance of an <i>UBA1</i> mutant clone over a <i>CALR</i> mutant clone: from essential thrombocytemia to VEXAS.

Circulating cytokines present in multiple myeloma patients inhibit the osteoblastic differentiation of adipose stem cells.

Collaborators (3)

Thierry Roger

Françoise PORTEU

Shengjiang Tan

Make your next move.